Inventor · disambiguated record
Stephen Willingham
Also filed as: WILLINGHAM STEPHEN
18 granted patents·5 pending applications·73 citations·filing 2014–2024
93Inventor score
Top patents by PatentIndex Score
23 records- 0198US11518806B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Dec 6, 2022·6 cites·34 claims
- 0297US11136391B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Oct 5, 2021·9 cites·17 claims
- 0396US11603404B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Mar 14, 2023·3 cites·36 claims
- 0496US9623079B2Methods for achieving therapeutically effective doses of anti-CD47 agents for treating cancerUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Apr 18, 2017·26 cites·12 claims
- 0594US10301387B2Methods for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 28, 2019·11 cites·15 claims
- 0691US10344094B2Treatment of cancer with dual targeting of CD47 and EGFRUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Jul 9, 2019·6 cites·9 claims
- 0786US12258403B2Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 0884US10064925B2Use of anti-CD47 agents to enhance immunizationUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Sep 4, 2018·7 cites·4 claims
- 0983US10912776B2Methods of treating cancerCORVUS PHARMACEUTICALS INC·Filed 2016·Granted Feb 9, 2021·3 cites·12 claims
- 1080US12258399B2Methods for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Mar 25, 2025·0 cites·18 claims
- 1180US2025066473A1Treatment of cancer with combinations of immunoregulatory agentsUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 1276US11040040B2Methods of treating cancerCORVUS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·2 cites·15 claims
- 1373US11104731B2Compositions for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Aug 31, 2021·0 cites·2 claims
- 1471US12037402B2Treatment of cancer with dual targeting of CD47 and EGFRUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jul 16, 2024·0 cites·7 claims
- 1570US11130813B2Treatment of cancer with dual targeting of CD47 and EGFRUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Sep 28, 2021·0 cites·8 claims
- 1666US2021230276A1Treatment of cancer with combinations of immunoregulatory agentsUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 1764US12023337B2Methods of treating cancerCORVUS PHARMACEUTICALS INC·Filed 2020·Granted Jul 2, 2024·0 cites·22 claims
- 1864US11154600B2Use of anti-CD47 agents to enhance immunizationUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Oct 26, 2021·0 cites·5 claims
- 1963US12174192B2Methods for detecting and treating cancers having adenosine pathway activationCORVUS PHARMACEUTICALS INC·Filed 2019·Granted Dec 24, 2024·0 cites·11 claims
- 2060US12116635B2Methods for detecting and treating cancers having adenosine pathway activationCORVUS PHARMACEUTICALS INC·Filed 2019·Granted Oct 15, 2024·0 cites·19 claims
- 2152US2024218073A1Immunomodulatory anti-cd73 antibodies and uses thereofCORVUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2250US2017210803A1Treatment of cancer with combinations of immunoregulatory agentsUNIV LELAND STANFORD JUNIOR·Filed 2017·Application pending·0 cites
- 2342US2019022096A1Methods of treating cancerCORVUS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →